Blood pressure control in type II diabetics with diabetic retinopathy.
BACKGROUND
Large clinical trials have emphasized that blood pressure control provides a major clinical benefit in reducing the risk of blindness in patients with diabetic retinopathy.


METHODS
This audit was carried out to assess the quality of care for hypertension in 100 consecutive type II diabetics with diabetic retinopathy.


RESULTS
The target blood pressure of 140/80 mmHg was achieved only in 38% of the patients. We also observed that 65% of the patients requiring diabetic macular laser treatment in this cohort had suboptimal control. The factors associated with suboptimal blood pressure control are identified and discussed.


CONCLUSIONS
Despite the unequivocal fact that lowering BP significantly reduces morbidity and mortality in diabetics, the majority of patients are not treated to a goal BP.
Sivaprasad
S
S
West Kent Eye Centre, Princess Royal University Hospital, Orpington, Kent, UK. senswathi@aol.com
Jackson
H
H
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000959:Antihypertensive Agents / Q000008:administration & dosage; D001766:Blindness / Q000209:etiology / Q000517:prevention & control; D001794:Blood Pressure; D001795:Blood Pressure Determination / Q000706:statistics & numerical data; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000503:physiopathology; D003930:Diabetic Retinopathy / Q000150:complications* / Q000503:physiopathology; D004363:Drug Utilization; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D008485:Medical Audit; D008875:Middle Aged; D008991:Monitoring, Physiologic / Q000706:statistics & numerical data; D011787:Quality of Health Care
D000959:Antihypertensive Agents